Aurora Cannabis Earns Coveted GMP Certification For Australian Market, Here’s What It Means
Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB) said on Wednesday that it has obtained Good Manufacturing Practice (GMP) certification from Australia’s Therapeutic Goods Administration (TGA) for its Canadian production facilities, River and Ridge.
The TGA is in charge of regulating the supply, import, export, manufacturing and advertising of therapeutic goods in Australia.
Obtaining TGA’s GMP certification allows the Canadian cannabis giant to deliver cannabis products to Australia.
The license grants approval for Aurora to broaden its product range offerings in the country, comprising dried flower, resin cartridges, pastilles and oils.
The certification was granted on March 15, allowing the company to grow within the Australian medical cannabis market, which is rapidly expanding and estimated to be worth AUD 400 million ($261.1 million).
Pro tip for Benzinga readers: Secure your tickets for the conference ASAP. …